Trial Details
TERMINATEDBasic Information
| Clinical ID | c4127 |
|---|---|
| Identifier | NCT01016262 |
| Trial Title | Efficacy and Safety Study of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Proctitis, Ulcerative |
| Interventions | DRUG: MAX-002|DRUG: Placebo|DRUG: Canasa® |
Participant Information
| Sponsor | Forest Laboratories |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2009-11-30 |
|---|---|
| Primary Completion Date | 2011-07-31 |
| Completion Date | 2011-09-30 |